Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials.

Waters DD, Ho JE, DeMicco DA, Breazna A, Arsenault BJ, Wun CC, Kastelein JJ, Colhoun H, Barter P.

J Am Coll Cardiol. 2011 Apr 5;57(14):1535-45. doi: 10.1016/j.jacc.2010.10.047.

PMID:
21453832
[PubMed - indexed for MEDLINE]
Free Article
2.

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators.

N Engl J Med. 2005 Jul 21;353(3):238-48. Erratum in: N Engl J Med. 2005 Oct 13;353(15):1640.

PMID:
16034009
[PubMed - indexed for MEDLINE]
Free Article
3.

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

Newman CB, Szarek M, Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Demicco DA, Auster S, Fuller JH; Cards Investigators.

Diab Vasc Dis Res. 2008 Sep;5(3):177-83. doi: 10.3132/dvdr.2008.029.

PMID:
18777490
[PubMed - indexed for MEDLINE]
Free Article
4.

Acute onset and worsening of diabetes concurrent with administration of statins.

Ohmura C, Watada H, Hirose T, Tanaka Y, Kawamori R.

Endocr J. 2005 Jun;52(3):369-72.

PMID:
16006732
[PubMed - indexed for MEDLINE]
Free Article
5.

Reduction in cardiovascular events with atorvastatin in type 2 diabetes.

Clearfield M.

Curr Atheroscler Rep. 2006 Jan;8(1):9-10. No abstract available.

PMID:
16455007
[PubMed - indexed for MEDLINE]
6.

Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin.

Abourjaily HM, Alsheikh-Ali AA, Karas RH.

Am J Cardiol. 2003 Apr 15;91(8):999-1002, A7. No abstract available.

PMID:
12686348
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.

Jones PH, Cusi K, Davidson MH, Kelly MT, Setze CM, Thakker K, Sleep DJ, Stolzenbach JC.

Am J Cardiovasc Drugs. 2010;10(2):73-84. doi: 10.2165/10061630-000000000-00000.

PMID:
20136164
[PubMed - indexed for MEDLINE]
8.

Influences of statins on glucose tolerance in patients with type 2 diabetes mellitus.

Takano T, Yamakawa T, Takahashi M, Kimura M, Okamura A.

J Atheroscler Thromb. 2006 Apr;13(2):95-100.

PMID:
16733297
[PubMed - indexed for MEDLINE]
Free Article
9.

Chronic urticaria to atorvastatin.

Anliker MD, Wüthrich B.

Allergy. 2002 Apr;57(4):366. No abstract available.

PMID:
11906371
[PubMed - indexed for MEDLINE]
10.

Atorvastatin-induced severe thrombocytopenia.

González-Ponte ML, González-Ruiz M, Duvós E, Gutiérrez-Iñiguez MA, Olalla JI, Conde E.

Lancet. 1998 Oct 17;352(9136):1284. No abstract available.

PMID:
9788465
[PubMed - indexed for MEDLINE]
11.

[Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy].

Rubí S, Duch J, Ortín J, Setoain X, Pons F.

Rev Esp Med Nucl. 2006 Nov-Dec;25(6):393. Spanish. No abstract available.

PMID:
17173790
[PubMed - indexed for MEDLINE]
12.

Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.

Newman C, Tsai J, Szarek M, Luo D, Gibson E.

Am J Cardiol. 2006 Jan 1;97(1):61-7. Epub 2005 Nov 15.

PMID:
16377285
[PubMed - indexed for MEDLINE]
13.

Atorvastatin-clopidogrel interaction.

Martin PT, Denman R.

Circulation. 2003 Jun 24;107(24):e223; author reply e223. No abstract available.

PMID:
12821599
[PubMed - indexed for MEDLINE]
Free Article
14.

Risk factors for rhabdomyolysis with simvastatin and atorvastatin.

Golomb B, Evans M.

Drug Saf. 2006;29(12):1191; author reply 1191-2. No abstract available.

PMID:
17147465
[PubMed - indexed for MEDLINE]
15.

Atorvastatin-induced diaphragmatic muscle impairment.

Sulem P, Bagheri H, Faixo Y, Montastruc JL.

Ann Pharmacother. 2001 Oct;35(10):1292-3. No abstract available.

PMID:
11675865
[PubMed - indexed for MEDLINE]
16.

Alopecia associated with atorvastatin.

Segal AS.

Am J Med. 2002 Aug 1;113(2):171. No abstract available.

PMID:
12133763
[PubMed - indexed for MEDLINE]
17.

Toxic epidermal necrolysis from atorvastatin.

Pfeiffer CM, Kazenoff S, Rothberg HD.

JAMA. 1998 May 27;279(20):1613-4. No abstract available.

PMID:
9613909
[PubMed - indexed for MEDLINE]
18.

Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients.

Newman CB, Palmer G, Silbershatz H, Szarek M.

Am J Cardiol. 2003 Sep 15;92(6):670-6.

PMID:
12972104
[PubMed - indexed for MEDLINE]
19.

The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia.

Lam HC, Chu CH, Wei MC, Keng HM, Lu CC, Sun CC, Lee JK, Chuang MJ, Wang MC, Tai MH.

Exp Biol Med (Maywood). 2006 Jun;231(6):1010-5.

PMID:
16741040
[PubMed - indexed for MEDLINE]
20.

Atorvastatin and male infertility: is there a link?

Niederberger C.

J Androl. 2005 Jan-Feb;26(1):12. No abstract available.

PMID:
15611560
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk